4
Changes in Ownership
Solid Biosciences Inc. Filed Acc 0001193125-26-034083
Chief Medical Officer sold 28,335 shares at $6.44 ($182,390)
- Chief Medical Officer acquired 87,072 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Brooks Gabriel Chief Medical Officer | 2026-01-29 | Option exercise 10b5-1 | +58,847 | 96,818 | D | ||
| Brooks Gabriel Chief Medical Officer | 2026-01-31 | Option exercise 10b5-1 | +28,225 | 125,043 | D | ||
| Brooks Gabriel Chief Medical Officer | 2026-02-02 | Sale 10b5-1 | −28,335 | $6.44 | $182,390 | 96,708 | D |
| Derivatives | |||||||
| Brooks Gabriel Chief Medical Officer | 2026-01-29 | Option exercise · Performance Stock Units 10b5-1 | −58,847 | 0 | D | ||
| Brooks Gabriel Chief Medical Officer | 2026-01-29 | Grant or award · Employee Stock Option (Right to Buy) 10b5-1 | +207,450 | 207,450 | D | ||
| Brooks Gabriel Chief Medical Officer | 2026-01-29 | Grant or award · Restricted Stock Units 10b5-1 | +103,750 | 103,750 | D | ||
| Brooks Gabriel Chief Medical Officer | 2026-01-31 | Option exercise · Restricted Stock Units 10b5-1 | −28,225 | 84,675 | D | ||
| Open-market sales · 28,335 sh · avg $6.44 · $182,390 | |||||||
Loading xslF345X05/ownership.xml…